Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXCH.L Regulatory News (XCH)

  • There is currently no data for XCH

Form 8 (OPD) Xchanging PLC

16 Oct 2015 07:00

RNS Number : 4634C
Apollo Management VIII, L.P.
16 October 2015
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Apollo Investment Fund VIII, L.P.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Xchanging plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

2 October 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

16 October 2015

Contact name:

Laurie Medley

Telephone number:

+1 212 515 3200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEPKPDPNBDBFKD
Date   Source Headline
7th Apr 20157:00 amRNSMM4 amendment to earn-out terms
1st Apr 20152:06 pmRNSBlocklisting Interim Review
31st Mar 20154:54 pmRNSTotal Voting Rights
27th Mar 201511:09 amRNSDirector/PDMR Shareholding
24th Mar 20157:03 amRNSCMA provisional clearance
18th Mar 201511:48 amRNSDirector/PDMR Shareholding
18th Mar 201511:45 amRNSDirector/PDMR Shareholding
16th Mar 20159:46 amRNSDirector/PDMR Shareholding
11th Mar 20153:07 pmRNSTotal Voting Rights
5th Mar 20154:57 pmRNSHolding(s) in Company
3rd Mar 201510:58 amRNSDirector/PDMR Shareholding
27th Feb 20155:27 pmRNSDirector Declaration
26th Feb 20157:01 amRNSAcquisition
26th Feb 20157:01 amRNSFinal Results
13th Feb 20157:00 amRNSHolding(s) in Company
6th Feb 20157:00 amRNSAcquisition of Spikes Cavell
3rd Feb 20157:00 amRNSBlocklisting Interim Review
3rd Feb 20157:00 amRNSHolding(s) in Company
30th Jan 201511:43 amRNSHolding(s) in Company
27th Jan 20156:28 pmRNSHolding(s) in Company
23rd Dec 20143:01 pmRNSDirector/PDMR Shareholding
19th Dec 20147:00 amRNSAcquisition of Total Objects completed
9th Dec 20143:09 pmRNSTotal Objects Acquisition to Complete
5th Dec 20144:03 pmRNSDirector/PDMR Shareholding
4th Dec 20147:00 amRNSAgencyport CMA Referral
3rd Dec 20141:48 pmRNSHolding(s) in Company
2nd Dec 20143:14 pmRNSAgencyport CMA Update
27th Nov 201410:51 amRNSDirector/PDMR Shareholding
27th Nov 20147:00 amRNSInvestor Seminar
26th Nov 201412:46 pmRNSTotal Voting Rights
21st Nov 20141:01 pmRNSDirector Declaration
14th Nov 20147:51 amRNSWorkers' Compensation contract
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20145:12 pmRNSBlocklisting Interim Review
20th Oct 20142:59 pmRNSDirector/PDMR Shareholding
3rd Oct 201412:20 pmRNSBlocklisting Interim Review
1st Oct 20147:00 amRNSAgencyport CMA Order
24th Sep 20144:36 pmRNSDirector/PDMR Shareholding
17th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 201410:21 amRNSHolding(s) in Company
29th Aug 201411:11 amRNSDirector/PDMR Shareholding
12th Aug 20145:21 pmRNSTotal Voting Rights
1st Aug 20141:04 pmRNSBlocklisting Interim Review
31st Jul 20147:00 amRNSHalf Yearly Report
30th Jul 20147:00 amRNSTakes full ownership of Fondsdepot Bank
14th Jul 20145:31 pmRNSHolding(s) in Company
8th Jul 20147:00 amRNSMM4 amendment to earn-out terms
4th Jul 20147:00 amRNSAcquisition
3rd Jul 20147:00 amRNSAcquisition
24th Jun 20145:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.